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The standard treatment for post-stroke spasticity (PSS) is 
rehabilitation. Botulinum Toxin Type A (BoNT-A) injection is 
used in treatment for PSS. The dosing is not standardized 
across clinical practice and is based on expert 
recommendation. This review analyzes the efficacy of BoNT-
A injection on arm muscle tone and function compared with 
rehabilitation in adult patients with upper limb spasticity after 
stroke. 
Introduction
Efficacy of Botulinum Toxin Type A Injection Compared to 
Rehabilitation in the Treatment of Upper Limb Post-Stroke Spasticity 
ConclusionA Literature search was conducted through PubMed Clinical 
Queries and ScienceDirect in November 2019. 
Search terms:
“stroke AND botulinum toxin AND upper limb rehabilitation” 
“stroke AND onabotulinumtoxinA AND upper limb 
rehabilitation” 
Inclusion Criteria:
• Utilized BoNT-A in upper limb
• Compared to placebo injection or utilized rehabilitation in 
control and intervention group to isolate BoNT-A effect 
Exclusion Criteria:
• Systematic reviews or meta-analysis
• Adjunctive treatment in addition to BoNT-A or rehab 
• Diagnosis other than stroke
• Lower Limb spasticity 
Methods
Childers et al 
v Hypothesized that intramuscular BoNT-A reduces excessive muscle tone.
Devier et al 
v Studied the benefit of adding weekly rehabilitation to BoNT-A treatments for spasticity 
following stroke. 
Meythaler et al
v Studied if BoNT-A combined with therapy can facilitate improved upper limb function versus 
therapy alone. 
Prazeres et al  
v Investigated if BoNT-A with physical therapy is superior to therapy alone in post stroke 
spasticity.  
Rosales et al 
v Studied the effect of Botox plus rehabilitation on function of upper limb post stroke in 
comparison to placebo.
Shaw et al 
v Studied the clinical and cost-effectiveness of treating upper limb post stroke spasticity with 
Botox plus rehabilitation versus rehabilitation program alone. 
Ward et al 
v Investigated if BoNT-A  is able to significantly increase patient goal achievement and active 
function in addition to rehabilitation. 
Results
Table 2: Summary of Results for Efficacy of BoNT-A on Tone and Function of Upper Limb 
Study Reduction in Muscle Tone 
(Spasticity)
BoNT-A Improved Function
Childers et al (2004) S NS
Devier et al (2017) NS NS (rehab improved)
Meythaler et al (2009) NS S
Prazeres et al (2018) S S*
Rosales et al (2012) S NS
Shaw et al (2010) S NS
Ward et al (2014) S NS
Key: S = significant; NS = not significant; NA = Results Not Applicable, *improvement did not 
differ significantly than control group 
Upper limb muscle spasticity is a motor impairment that 
occurs after stroke. Early signs of spasticity are weakness in 
the limb and reduced muscle control leading to disability in 
function. Post stroke spasticity (PSS) is commonly 
measured using the Modified Ashworth Scale (MAS). A 
review of seven RCTs that utilized botulinum toxin type A in 
the treatment of post-stroke spasticity was conducted to 
evaluate its efficacy in comparison to rehabilitation as the 
standard of care. The studies had varying designs and 
outcome measures. While several of the studies supported 
short-term benefit of BoNT-A in reducing muscle spasticity, 
the evidence was underwhelming for improving consistent 
function of upper limb in comparison to rehabilitation alone. 
Abstract 
Synthesis of Evidence: 
• 5 of 7 RCT report à BoNT-A reduced muscle tone 
compared to placebo/rehabilitation alone  
• 2 of 7 RCT report à functional improvement in the 
limb with BoNT-A using outcome measures of function
Strengths:
• All seven studies were randomized clinical trials 
(RCT)
• Studies reported minimal side effects of BoNT-A
• Studies recommend therapy as continued standard of 
care
Limitations:
• Variability in sample size and intervention and control 
groups
• Small sample sizes and unclear rehabilitation 
protocols
• Funding Bias 
• Lacked consistent outcome measures of muscle tone 
and functionality across studies. 
Future Research: 
• Function of the upper limb post-stroke is multifactorial. 
Spasticity is one factor that can be targeted. Targeting 
additional factors and improving on limitations listed
vBoNT-A effects are most significant with decreasing 
upper limb muscle tone (spasticity).
vThis evidence-based review article supports 
rehabilitation as continued standard of care.
vBoNT-A as adjunct treatment to rehabilitation therapy  
for patients suffering from post-stroke spasticity 
vPatients should be informed of lack of strong evidence 
to support increased function from rehabilitation alone 
vLong-term significance of muscle tone and function 
improvement not well studied 
Discussion
Table 1: Comparison of Research Designs
Study Design Total N Control Intervention Outcome 
Measure of 
Muscle Tone
Outcome Measure of 
Function
Childers RCT 91 Placebo + Rehab BoNT-A + Rehab MAS FIM, SF-36
Devier RCT 31 BoNT-A alone BoNT-A + Rehab MAS FMA, DAS
Meythaler RCT 21 Placebo + Rehab BoNT-A + Rehab MAS MAL, SF-36
Prazeres RCT 40 Placebo + Rehab BoNT-A + Rehab MAS TUG test, 6 MWT, FMA
Rosales RCT 163 Placebo + rehab BoNT-A + Rehab MAS FMA
Shaw RCT 333 Rehab only BoNT-A + Rehab MAS ARAT, pain
Ward RCT 274 Placebo + Rehab BoNT-A + Rehab REPAS GAS
